Conditions

Fill in the case form

• Coronary artery disease

  冠心病

  Blocked heart arteries are treated with stents (PCI) or bypass surgery (CABG). China performs both at enormous volume in public hospitals, at government-regulated prices. Below are the official numbers, with sources.

• Brain tumor

  脑肿瘤

  Brain tumor surgery is where surgeon volume matters most. China's top neurosurgery centers operate at a scale that exists almost nowhere else. Once you register there, imaging is done promptly and difficult cases go to multidisciplinary review — the system moves fast.

• Heart valve disease

  心脏瓣膜病

  Failing mitral or aortic valves are repaired or replaced by open surgery or, increasingly, by catheter. China's top cardiac centers do this at very high volume, and the surgical fees are set in public provincial catalogs.

• Lung cancer

  肺癌

  China treats more lung cancer than any country on earth, and its top thoracic centers operate almost entirely thoracoscopically. Surgery fees are government-listed; the numbers below are sourced.

• Liver cancer

  肝癌

  Nowhere in the world operates on more liver cancer than China's top centers — a direct consequence of scale. For patients from high-incidence countries, this is the deepest pool of surgical experience there is.

• Cataract

  白内障

  The world's most common operation, at some of the world's lowest published public prices: China's procurement reform cut artificial lens prices by half or more, and People's Daily ran the headline that cataract surgery fees had fallen to the thousand-yuan level.

• Hip and knee osteoarthritis

  髋膝关节炎

  When a worn hip or knee ends walking, replacement gives the decade back. China's procurement reform cut implant prices by about 80%, making its public hospitals one of the world's best-value places for this operation.

• Lumbar disc herniation

  腰椎间盘突出

  Most herniated discs never need surgery — that judgment belongs to your doctors. For the cases that do, China's spine centers offer the full ladder, from keyhole endoscopic discectomy to instrumented fusion, at government-listed fees.

• Brain aneurysm & AVM

  脑动脉瘤

  An unruptured aneurysm is elective lifesaving surgery — found in time, it can be planned calmly, which makes it well suited to treatment abroad. China's top cerebrovascular centers offer both open clipping and endovascular coiling at government-listed fees.

• Parkinson's disease

  帕金森病

  For drug-refractory Parkinson's, deep brain stimulation (DBS) gives movement back. China implants DBS at high volume — and now manufactures the full system domestically, which cuts the device bill roughly in half compared with import-only countries.

• Aortic aneurysm & dissection

  主动脉瘤/主动脉夹层

  Aortic dissection is measured in hours, and aneurysm repair in experience. China holds a special position here: the Sun procedure — total arch replacement with a stented elephant trunk — was invented in China, and Chinese centers perform more of these operations than anywhere else.

• Pancreatic cancer

  胰腺癌

  The Whipple operation is often called the Everest of abdominal surgery — and in surgery, Everest should be climbed with the team that climbs it weekly. China's high-volume pancreatic centers do exactly that, at government-listed fees.

• Nasopharyngeal cancer

  鼻咽癌

  Nasopharyngeal cancer clusters in one belt of the world: southern China, Vietnam, Indonesia, Malaysia. The disease's global capital of treatment sits inside that belt — Guangzhou — where the world's largest NPC center treats more of it than anywhere on earth, a direct flight from Hanoi or Jakarta.

• Leukemia & lymphoma

  白血病/淋巴瘤

  For blood cancers that outrun chemotherapy, the two heavy weapons are stem-cell transplantation and CAR-T. China holds a unique card in the first: the haploidentical 'Beijing Protocol', invented at Peking University People's Hospital, lets a parent, child or sibling serve as donor — so nearly every patient has one.

• Severe scoliosis

  重度脊柱侧弯

  Severe spinal deformity correction is among the most demanding of all orthopedic operations — and one of the least available in Southeast Asia. China's two most renowned scoliosis programs each correct more curves in a year than many countries do in a decade.

• Colorectal cancer

  结直肠癌

  The most common major cancer in men across much of Asia — and one where the surgical question that matters most to patients is sphincter preservation. China's specialist colorectal centers answer it at enormous volume, at government-listed fees.

• Gastric cancer

  胃癌

  Gastric cancer is East Asia's cancer — and East Asia is where it is operated on best. China's gastric flagships run standardized D2 radical surgery at volumes Western centers never accumulate.

• Esophageal cancer

  食管癌

  Roughly half of the world's esophageal cancer cases occur in China — no country's surgeons see more of this disease. If volume builds mastery anywhere, it is here.

• Breast cancer

  乳腺癌

  The most common cancer in women worldwide — and one where China's flagship breast centers combine very high surgical volume with strikingly low listed fees. Reconstruction can be done in the same operation or staged later.

• Thalassemia

  地中海贫血

  An inherited blood disorder. Severe forms require lifelong transfusions and iron chelation — unless cured. A stem cell transplant is currently the only established cure, and the world's single most experienced transplant program for this disease is in Nanning, Guangxi.

• Congenital heart disease (children)

  先天性心脏病

  Holes in the heart (VSD, ASD), patent ductus arteriosus and complex defects such as tetralogy of Fallot are among the most routinely fixed problems in pediatric medicine — by open repair or by a catheter-based closure that needs no open surgery at all. China treats them at world-leading volume, at government-listed prices.

• Cervical cancer

  宫颈癌

  Treatment is well defined at every stage: cone excision for early lesions, radical hysterectomy with lymph node dissection for operable cancer, and chemoradiation for locally advanced disease. China's top gynecologic oncology centers run all three paths at high volume, at government-listed prices.